Share This Page
Drug Price Trends for NDC 43547-0612
✉ Email this page to a colleague
Average Pharmacy Cost for 43547-0612
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| TEMAZEPAM 15 MG CAPSULE | 43547-0612-10 | 0.07602 | EACH | 2025-11-19 |
| TEMAZEPAM 15 MG CAPSULE | 43547-0612-50 | 0.07602 | EACH | 2025-11-19 |
| TEMAZEPAM 15 MG CAPSULE | 43547-0612-10 | 0.07560 | EACH | 2025-10-22 |
| TEMAZEPAM 15 MG CAPSULE | 43547-0612-50 | 0.07560 | EACH | 2025-10-22 |
| TEMAZEPAM 15 MG CAPSULE | 43547-0612-10 | 0.07631 | EACH | 2025-09-17 |
| TEMAZEPAM 15 MG CAPSULE | 43547-0612-50 | 0.07631 | EACH | 2025-09-17 |
| TEMAZEPAM 15 MG CAPSULE | 43547-0612-10 | 0.07692 | EACH | 2025-08-20 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 43547-0612
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 43547-0612
Introduction
The pharmaceutical landscape constantly evolves, influenced by advances in science, regulatory changes, market demands, and patent landscapes. This report provides an in-depth market analysis and price projections for the drug identified by NDC 43547-0612. By examining current market conditions, competitive positioning, regulatory environment, and anticipated trends, stakeholders can make informed decisions regarding investment, pricing strategies, and market penetration.
Product Profile and Therapeutic Indication
The National Drug Code (NDC) 43547-0612 corresponds to [Drug Name], a [drug class] primarily indicated for [condition/therapy area]. It is positioned within the [specific therapeutic segment, e.g., oncology, immunology, cardiology], serving a patient population characterized by [key demographics, prevalence figures].
The drug's mechanism of action involves [brief description], and it benefits patients through [notable efficacy, safety profile, or improved administration].
Market Landscape Analysis
Market Size and Patient Demographics
The target market for [Drug Name] encompasses [number] million patients globally, with [region-specific] accounting for approximately [percentage or number]. The US market dominates due to high prevalence, advanced healthcare infrastructure, and reimbursement capabilities, representing up to [percentage] of total market value.
Prevalence data underscore a steady increase in the patient pool, driven by [factors: aging population, disease awareness, improved diagnostics]. For example, [condition] affects [statistics], establishing a significant demand that is projected to grow at [compound annual growth rate, CAGR] over the next [years].
Competitive Landscape
The competitive environment features [number] key players, including [major competitors, e.g., Pfizer, Novartis, or biosimilar manufacturers]. The competitive advantages of [Drug Name] hinge on factors such as [clinical efficacy, safety profile, ease of administration, patent exclusivity, or market access].
Patent protections are critical; currently, the patent landscape indicates [expiration date or ongoing patent litigations], influencing the potential for biosimilar or generic competition.
Regulatory Environment and Reimbursement
Regulatory approvals are secured in [list areas, e.g., US (FDA), EU (EMA), other jurisdictions], with ongoing submissions or supplemental indications in progress. Reimbursement policies vary, with payer coverage hinging on [cost-effectiveness, clinical data, formulary access]. Price negotiations with payers remain pivotal, especially in the context of value-based care initiatives.
Current Market Performance
As of 2023, [Drug Name] has achieved [sales figures, e.g., $X million] in annual revenue, reflecting a [percentage] increase from the previous year. Market penetration is facilitated by [distribution channels, patient access programs, physician adoption rates]. Key barriers include [stiff competition, pricing pressures, or logistical challenges].
The drug's adoption is bolstered by [novel delivery system, combination therapy benefits, or favorable clinical trial outcomes].
Price Projection Methodology
Predicting future drug prices involves analyzing multiple factors:
- Regulatory and patent expirations
- Market competition and biosimilar entry
- Cost of manufacturing and supply chain dynamics
- Reimbursement landscape and payer negotiations
- Pipeline development and new indications
The projection model considers historical pricing trends, recent pricing strategies, and anticipated regulatory and market developments.
Price Projections (Next 3-5 Years)
Base Case Scenario
Assuming current patent protections remain intact and market conditions are stable, [Drug Name] is expected to sustain an average wholesale price (AWP) of $[X] per [dose/unit] over the next [years]. However, incremental price adjustments will likely occur in response to [inflation, supply chain costs, or value-based negotiations].
Following U.S. inflation trends (approximately [percentage] annually), a conservative increase of [percentage] per year forecasts a price of approximately $[Y] per [dose/unit] by [year].
Impact of Patent Expiry and Biosimilar Entry
Patent expiry anticipated around [year] could usher in biosimilar competition, exerting downward pressure. Price erosion could range from [percentage] to [percentage], leading to an expected price range of $[lower bound] - $[upper bound] post-generic/biosimilar entry.
Influence of Market Access and Payer Negotiations
Payers increasingly favor cost-effective therapies. As negotiations intensify, net prices are projected to decrease by [percentage], especially if alternative therapies demonstrate comparable efficacy.
Additionally, value-based contracts could modify pricing dynamically based on real-world outcomes, further influencing trajectory.
Potential Price Trends and Innovations
Innovations such as [improved formulations, extended-release versions, or combination therapies] can shift pricing strategies. For instance, improved formulations might command premium pricing, while the entry of biosimilars would necessitate significant price competition.
Future Market Outlook
The global market for [therapeutic class] is projected to reach $[X] billion by [year], growing at a CAGR of [percentage]. The success of [Drug Name] will depend on [clinical positioning, regulatory milestones, and market acceptance].
Emerging therapies, such as [novel agents or gene therapies], could alter the competitive landscape, impacting long-term pricing and market share.
Key Factors Influencing Price Dynamics
- Patent Life and Exclusivity Periods: The remaining patent life influences price stability.
- Competition and Biosimilars: Biosimilar entry tends to reduce prices significantly, often by [percentage], within [years].
- Regulatory Pathways: Approvals for expanded indications may enhance revenue potential but could influence pricing strategies.
- Market Penetration: Increased adoption driven by clinical efficacy and payer coverage impacts revenue and, consequently, pricing strategies.
- Reimbursement Policies: Policies favoring value-based reimbursement systems can pressure list prices downward.
Conclusion
The market for [Drug Name] driven by NDC 43547-0612 presents a dynamic environment characterized by steady demand, competitive pressures, and evolving regulatory landscapes. Pricing strategies should consider patent protections, potential biosimilar competition, and negotiation power with payers. In the absence of imminent patent expiry, prices are expected to trend modestly upward, with significant downward adjustments post-patent expiration due to biosimilar entry.
Stakeholders should monitor patent timelines, regulatory milestones, and market competition to optimize pricing and market strategies.
Key Takeaways
- Market expansion for [Drug Name] is driven by increasing prevalence and improved diagnosis within its therapeutic area.
- Price projections over the next 3-5 years suggest stability with incremental increases, barring biosimilar competition.
- Patent expiration—anticipated around [year]—could significantly reduce prices by [percentage], fostering biosimilar uptake.
- Reimbursement negotiations and value-based care are critical determinants of net pricing.
- Investing in clinical differentiation and expanding indications can support premium pricing and market share stability.
FAQs
1. When is the patent for NDC 43547-0612 expected to expire?
Patent expiration is projected around [year], after which biosimilar competitors are likely to enter the market, impacting pricing.
2. How does biosimilar entry affect the pricing of [Drug Name]?
Biosimilar competition generally results in price reductions of [percentage range], often leading to substantially lower patient and payer costs.
3. What factors could accelerate or decelerate the price decline post-patent?
Accelerators include rapid biosimilar approval, strong payer resistance to high prices, and market saturation. Decelerators involve regulatory delays, limited biosimilar uptake, and strategic patent extensions.
4. How are regulatory changes influencing future pricing strategies?
Regulatory pathways favoring broader indications and expedited approvals can enhance revenue, while strict reimbursement criteria and cost-containment measures exert downward pressure on prices.
5. What role do value-based contracts play in long-term pricing?
Value-based contracts tie payments to clinical outcomes, potentially stabilizing or increasing net revenues, but they introduce pricing complexity and require robust post-market surveillance.
References
- [Source 1]: Market size and prevalence data (e.g., CDC, IMS Health).
- [Source 2]: Patent expiration timelines (e.g., FDA Orange Book).
- [Source 3]: Competitive landscape reports (e.g., EvaluatePharma, IQVIA).
- [Source 4]: Regulatory environment analysis (e.g., FDA, EMA updates).
- [Source 5]: Price trend analyses and biosimilar impact studies (e.g., health economics journals).
This comprehensive analysis provides an actionable framework for stakeholders engaging with NDC: 43547-0612, underpinning strategic decisions grounded in current market realities and future projections.
More… ↓
